Ginkgo Bioworks Holdings

Company Profile

Ginkgo Bioworks Holdings had its IPO on 2021-04-19 under the ticker symbol DNA.

The company operates in the Healthcare sector and Biotechnology industry. Ginkgo Bioworks Holdings has a staff strength of 1,292 employees.

Stock update

Shares of Ginkgo Bioworks Holdings opened at $2.08 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.04 - $2.17, and closed at $2.07.

This is a -0.96% slip from the previous day's closing price.

A total volume of 12,186,806 shares were traded at the close of the day’s session.

In the last one week, shares of Ginkgo Bioworks Holdings have slipped by -8%.

Ginkgo Bioworks Holdings's Key Ratios

Ginkgo Bioworks Holdings has a market cap of $3.44 billion, indicating a price to book ratio of 2.4609 and a price to sales ratio of 5.9899.

In the last 12-months Ginkgo Bioworks Holdings’s revenue was $390.00 million with a gross profit of $273.49 million and an EBITDA of $-1692385024. The EBITDA ratio measures Ginkgo Bioworks Holdings's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Ginkgo Bioworks Holdings’s operating margin was -447.9% while its return on assets stood at -48.79% with a return of equity of -106.7%.

In Q1, Ginkgo Bioworks Holdings’s quarterly earnings growth was a positive 0% while revenue growth was a negative 52.1%.

Ginkgo Bioworks Holdings’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.93 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ginkgo Bioworks Holdings’s profitability.

Ginkgo Bioworks Holdings stock is trading at a EV to sales ratio of 4.334 and a EV to EBITDA ratio of -0.6303. Its price to sales ratio in the trailing 12-months stood at 5.9899.

Ginkgo Bioworks Holdings stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$2.42 billion

Total Liabilities

$191.70 million

Operating Cash Flow

$-19414000.00

Capital Expenditure

$19.44 million

Dividend Payout Ratio

0%

Ginkgo Bioworks Holdings ended 2024 with $2.42 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $2.42 billion while shareholder equity stood at $1.61 billion.

Ginkgo Bioworks Holdings ended 2024 with $174.82 million in deferred long-term liabilities, $191.70 million in other current liabilities, 194000.00 in common stock, $-4602628000.00 in retained earnings and $58.73 million in goodwill. Its cash balance stood at $1.21 billion and cash and short-term investments were $1.21 billion. The company’s total short-term debt was $0 while long-term debt stood at $0.

Ginkgo Bioworks Holdings’s total current assets stands at $1.33 billion while long-term investments were $121.75 million and short-term investments were $0. Its net receivables were $84.84 million compared to accounts payable of $21.57 million and inventory worth $2.51 million.

In 2024, Ginkgo Bioworks Holdings's operating cash flow was $-19414000.00 while its capital expenditure stood at $19.44 million.

Comparatively, Ginkgo Bioworks Holdings paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.07

52-Week High

$4.91

52-Week Low

$1.12

Analyst Target Price

$4.46

Ginkgo Bioworks Holdings stock is currently trading at $2.07 per share. It touched a 52-week high of $4.91 and a 52-week low of $4.91. Analysts tracking the stock have a 12-month average target price of $4.46.

Its 50-day moving average was $2.04 and 200-day moving average was $1.69 The short ratio stood at 11.05 indicating a short percent outstanding of 0%.

Around 920.8% of the company’s stock are held by insiders while 7373.2% are held by institutions.